SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy.

Jae Kyu RyuElif G SozmenKaruna DixitMauricio MontanoYusuke MatsuiYixin LiuEkram HelmyThomas J DeerinckZhaoqi YanRenaud SchuckRosa Meza AcevedoCollin M SpencerReuben ThomasAlexander R PicoScott S ZamvilKara L LynchMark H EllismanWarner C GreeneKaterina Akassoglou

Published in: bioRxiv : the preprint server for biology (2021)

SARS-CoV-2 spike induces structurally abnormal blood clots and thromboinflammation neutralized by a fibrin-targeting antibody.

Keyphrases

sars cov
respiratory syndrome coronavirus
platelet rich plasma
oxidative stress
cancer therapy
protein protein
coronavirus disease